Financial Instrument Risk Exposure and Risk Management (Details) - CAD ($) |
12 Months Ended | 15 Months Ended |
|---|---|---|
Sep. 30, 2024 |
Dec. 31, 2025 |
|
| Disclosure of detailed information about financial instruments [line items] | ||
| Financial assets | $ 108,901,729 | |
| Interest rate | 1.00% | |
| Annual interest expense | $ 16,700 | $ 407,000 |
| Net loss | (3,085,195) | (16,972,421) |
| Foreign currency risk [Member] | ||
| Disclosure of detailed information about financial instruments [line items] | ||
| Cash and cash equivalents | 304,052 | 3,413,202 |
| Reclamation deposit | 59,052 | 59,951 |
| Receivables | 19,312 | 12,900 |
| Consideration Payable | 3,374,750 | 1,713,250 |
| Accounts payable and accrued liabilities | 167,283 | $ 367,714 |
| Currency exchange rate, percentage | 10.00% | |
| Net loss | $ 315,967 | $ 140,448 |
| X | ||||||||||
- Definition Amount of accounts payable and accrued liabilities. No definition available.
|
| X | ||||||||||
- Definition The amount of annual interest expense. No definition available.
|
| X | ||||||||||
- Definition Amount of consideration payable. No definition available.
|
| X | ||||||||||
- Definition Percentage of currency exchange rate. No definition available.
|
| X | ||||||||||
- Definition The interest rate on borrowings. [Refer: Borrowings] Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of deposit liabilities held by the entity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. No definition available.
|
| X | ||||||||||
- Definition The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity’s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity’s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity’s own equity instruments. For this purpose the entity’s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity’s own equity instruments. [Refer: Classes of financial instruments [domain]; Financial liabilities] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of cash and cash equivalents that the entity does not separately disclose in the same statement or note. [Refer: Cash and cash equivalents] Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount receivable by the entity that it does not separately disclose in the same statement or note. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|